{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:27:37Z","timestamp":1794569257959,"version":"4.9.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103912"],"award-info":[{"award-number":["82103912"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204129"],"award-info":[{"award-number":["82204129"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173591"],"award-info":[{"award-number":["82173591"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202312328"],"award-info":[{"award-number":["tsqn202312328"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tstp20230654"],"award-info":[{"award-number":["tstp20230654"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QH162"],"award-info":[{"award-number":["ZR2022QH162"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57879-3","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T01:14:49Z","timestamp":1742606089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Associations of 2923 plasma proteins with incident inflammatory bowel disease in a prospective cohort study and genetic analysis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9987-030X","authenticated-orcid":false,"given":"Xuening","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8799-8533","authenticated-orcid":false,"given":"Hao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4675-1577","authenticated-orcid":false,"given":"Meng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5491-3882","authenticated-orcid":false,"given":"Tongchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9866-3029","authenticated-orcid":false,"given":"Xiaorong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8685-6322","authenticated-orcid":false,"given":"Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"57879_CR1","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng, S. C. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet (Lond., Engl.) 390, 2769\u20132778 (2017).","journal-title":"Lancet (Lond., Engl.)"},{"key":"57879_CR2","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","volume":"12","author":"GG Kaplan","year":"2015","unstructured":"Kaplan, G. G. The global burden of IBD: from 2015 to 2025. Nat. Rev. Gastroenterol. Hepatol. 12, 720\u2013727 (2015).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"57879_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.autrev.2004.03.002","volume":"3","author":"S Danese","year":"2004","unstructured":"Danese, S., Sans, M. & Fiocchi, C. Inflammatory bowel disease: the role of environmental factors. Autoimmun. Rev. 3, 394\u2013400 (2004).","journal-title":"Autoimmun. Rev."},{"key":"57879_CR4","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1136\/gutjnl-2022-327025","volume":"71","author":"S Danese","year":"2022","unstructured":"Danese, S., Solitano, V., Jairath, V. & Peyrin-Biroulet, L. The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment). Gut 71, 2380\u20132387 (2022).","journal-title":"Gut"},{"key":"57879_CR5","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.jacc.2023.09.804","volume":"82","author":"M Mazidi","year":"2023","unstructured":"Mazidi, M. et al. Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease. J. Am. Coll. Cardiol. 82, 1906\u20131920 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"57879_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","volume":"1","author":"KA Walker","year":"2021","unstructured":"Walker, K. A. et al. Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk. Nat. aging 1, 473\u2013489 (2021).","journal-title":"Nat. aging"},{"key":"57879_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.121.056663","volume":"145","author":"A Henry","year":"2022","unstructured":"Henry, A. et al. Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization. Circulation 145, 1205\u20131217 (2022).","journal-title":"Circulation"},{"key":"57879_CR8","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.2337\/dc23-2145","volume":"47","author":"P Yao","year":"2024","unstructured":"Yao, P. et al. Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes. Diab. Care 47, 1012\u20131019 (2024).","journal-title":"Diab. Care"},{"key":"57879_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.trsl.2012.01.001","volume":"159","author":"HN Iskandar","year":"2012","unstructured":"Iskandar, H. N. & Ciorba, M. A. Biomarkers in inflammatory bowel disease: current practices and recent advances. Transl. Res.: J. Lab. Clin. Med. 159, 313\u2013325 (2012).","journal-title":"Transl. Res.: J. Lab. Clin. Med."},{"key":"57879_CR10","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1136\/gutjnl-2015-310705","volume":"66","author":"AE Starr","year":"2017","unstructured":"Starr, A. E. et al. Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn\u2019s disease from UC. Gut 66, 1573\u20131583 (2017).","journal-title":"Gut"},{"key":"57879_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/ecco-jcc\/jjaa230","volume":"15","author":"R Kalla","year":"2021","unstructured":"Kalla, R. et al. Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease. J. Crohns Colitis 15, 699\u2013708 (2021).","journal-title":"J. Crohns Colitis"},{"key":"57879_CR12","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/ecco-jcc\/jjz012","volume":"13","author":"C Deutschmann","year":"2019","unstructured":"Deutschmann, C. et al. Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn\u2019s Disease. J. Crohns Colitis 13, 894\u2013904 (2019).","journal-title":"J. Crohns Colitis"},{"key":"57879_CR13","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1053\/j.gastro.2010.11.058","volume":"140","author":"JD Lewis","year":"2011","unstructured":"Lewis, J. D. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 140, 1817\u20131826.e1812 (2011).","journal-title":"Gastroenterology"},{"key":"57879_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn, G. H. et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature 622, 348\u2013358 (2023).","journal-title":"Nature"},{"key":"57879_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.gastro.2020.03.007","volume":"159","author":"J Torres","year":"2020","unstructured":"Torres, J. et al. Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis. Gastroenterology 159, 96\u2013104 (2020).","journal-title":"Gastroenterology"},{"key":"57879_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/ecco-jcc\/jjac191","volume":"17","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. Bidirectional Mendelian Randomisation Analysis Provides Evidence for the Causal Involvement of Dysregulation of CXCL9, CCL11 and CASP8 in the Pathogenesis of Ulcerative Colitis. J. Crohns Colitis 17, 777\u2013785 (2023).","journal-title":"J. Crohns Colitis"},{"key":"57879_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith, G. D. & Ebrahim, S. \u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J. Epidemiol. 32, 1\u201322 (2003).","journal-title":"Int J. Epidemiol."},{"key":"57879_CR18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41591-021-01281-1","volume":"27","author":"S Zhou","year":"2021","unstructured":"Zhou, S. et al. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity. Nat. Med 27, 659\u2013667 (2021).","journal-title":"Nat. Med"},{"key":"57879_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"57879_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41586-023-06547-x","volume":"622","author":"RS Dhindsa","year":"2023","unstructured":"Dhindsa, R. S. et al. Rare variant associations with plasma protein levels in the UK Biobank. Nature 622, 339\u2013347 (2023).","journal-title":"Nature"},{"key":"57879_CR21","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"47","author":"JZ Liu","year":"2015","unstructured":"Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet 47, 979\u2013986 (2015).","journal-title":"Nat. Genet"},{"key":"57879_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518 (2023).","journal-title":"Nature"},{"key":"57879_CR23","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet 53, 1712\u20131721 (2021).","journal-title":"Nat. Genet"},{"key":"57879_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj1541","volume":"374","author":"M Pietzner","year":"2021","unstructured":"Pietzner, M. et al. Mapping the proteo-genomic convergence of human diseases. Science. (N.Y., NY) 374, eabj1541 (2021).","journal-title":"Science. (N.Y., NY)"},{"key":"57879_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40156-6","volume":"14","author":"A Garrido-Trigo","year":"2023","unstructured":"Garrido-Trigo, A. et al. Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease. Nat. Commun. 14, 4506 (2023).","journal-title":"Nat. Commun."},{"key":"57879_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.4161\/mabs.3.6.17815","volume":"3","author":"JM Benson","year":"2011","unstructured":"Benson, J. M. et al. Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders. mAbs 3, 535\u2013545 (2011).","journal-title":"mAbs"},{"key":"57879_CR27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","volume":"381","author":"BE Sands","year":"2019","unstructured":"Sands, B. E. et al. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. N. Engl. J. Med 381, 1201\u20131214 (2019).","journal-title":"N. Engl. J. Med"},{"key":"57879_CR28","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0016-5085(98)70106-4","volume":"115","author":"LJ Egan","year":"1998","unstructured":"Egan, L. J. & Sandborn, W. J. Inhibition of nuclear factor kappaB by sulfasalazine: a new target for inflammatory bowel disease therapy? Gastroenterology 115, 1295\u20131296 (1998).","journal-title":"Gastroenterology"},{"key":"57879_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-2249.2006.03214.x","volume":"146","author":"R Ito","year":"2006","unstructured":"Ito, R. et al. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin. Exp. Immunol. 146, 330\u2013338 (2006).","journal-title":"Clin. Exp. Immunol."},{"key":"57879_CR30","unstructured":"GlaxoSmithKline. A. Single-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Intravenously Infused GSK1070806 in Healthy and Obese Subjects.: clinicaltrials.gov, 2017."},{"key":"57879_CR31","unstructured":"Birmingham, U. O. A Phase Ib\/IIb, Randomised, Double Blind, Placebo-Controlled Trial to Investigate the Safety, Tolerability and Clinical Activity of Humanised Antibody GSK1070806 in the Treatment of Patients With Moderate-to-Severe Crohn\u2019s Disease: clinicaltrials.gov, 2021."},{"key":"57879_CR32","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/ecco-jcc\/jjy179","volume":"13","author":"C Ma","year":"2019","unstructured":"Ma, C. et al. Critical Role of CD6highCD4+ T Cells in Driving Th1\/Th17 Cell Immune Responses and Mucosal Inflammation in IBD. J. Crohns Colitis 13, 510\u2013524 (2019).","journal-title":"J. Crohns Colitis"},{"key":"57879_CR33","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/oby.24000","volume":"32","author":"S Sathyan","year":"2024","unstructured":"Sathyan, S. et al. Plasma proteomic profile of abdominal obesity in older adults. Obes. (Silver Spring) 32, 938\u2013948 (2024).","journal-title":"Obes. (Silver Spring)"},{"key":"57879_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00251-022-01274-5","volume":"74","author":"WM Zhong","year":"2022","unstructured":"Zhong, W. M., Qian, X. H. & Jin, Z. W. Identification of potential predictive biomarkers and biological pathways and the correction with immune infiltration in the activation of Crohn\u2019s disease. Immunogenetics 74, 527\u2013537 (2022).","journal-title":"Immunogenetics"},{"key":"57879_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/ibd\/izab123","volume":"28","author":"G Boucher","year":"2022","unstructured":"Boucher, G. et al. Serum Analyte Profiles Associated With Crohn\u2019s Disease and Disease Location. Inflamm. Bowel Dis. 28, 9\u201320 (2022).","journal-title":"Inflamm. Bowel Dis."},{"key":"57879_CR36","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3390\/ijms21051846","volume":"21","author":"L Xu","year":"2020","unstructured":"Xu, L. et al. High-Dose Dexamethasone Manipulates the Tumor Microenvironment and Internal Metabolic Pathways in Anti-Tumor Progression. Int J. Mol. Sci. 21, 1846 (2020).","journal-title":"Int J. Mol. Sci."},{"key":"57879_CR37","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.2337\/db15-0617","volume":"65","author":"C Martinerie","year":"2016","unstructured":"Martinerie, C. et al. NOV\/CCN3: A New Adipocytokine Involved in Obesity-Associated Insulin Resistance. Diabetes 65, 2502\u20132515 (2016).","journal-title":"Diabetes"},{"key":"57879_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cca.2019.03.006","volume":"494","author":"JY Li","year":"2019","unstructured":"Li, J. Y. et al. Serum CCN3 levels are increased in type 2 diabetes mellitus and associated with obesity, insulin resistance and inflammation. Clin. Chim. acta; Int. J. Clin. Chem. 494, 52\u201357 (2019).","journal-title":"Clin. Chim. acta; Int. J. Clin. Chem."},{"key":"57879_CR39","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1136\/gutjnl-2016-311606","volume":"66","author":"J Hilkens","year":"2017","unstructured":"Hilkens, J. et al. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis. Gut 66, 1095\u20131105 (2017).","journal-title":"Gut"},{"key":"57879_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15704-y","volume":"7","author":"MM Fischer","year":"2017","unstructured":"Fischer, M. M. et al. RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations. Sci. Rep. 7, 15270 (2017).","journal-title":"Sci. Rep."},{"key":"57879_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175613","volume":"945","author":"M Allodi","year":"2023","unstructured":"Allodi, M. et al. Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20\/CCR6 axis. Eur. J. Pharmacol. 945, 175613 (2023).","journal-title":"Eur. J. Pharmacol."},{"key":"57879_CR42","doi-asserted-by":"publisher","first-page":"102846","DOI":"10.1016\/j.autrev.2021.102846","volume":"20","author":"HT Meitei","year":"2021","unstructured":"Meitei, H. T., Jadhav, N. & Lal, G. CCR6-CCL20 axis as a therapeutic target for autoimmune diseases. Autoimmun. Rev. 20, 102846 (2021).","journal-title":"Autoimmun. Rev."},{"key":"57879_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.imlet.2009.11.001","volume":"128","author":"JB Seidelin","year":"2010","unstructured":"Seidelin, J. B. et al. IL-33 is upregulated in colonocytes of ulcerative colitis. Immunol. Lett. 128, 80\u201385 (2010).","journal-title":"Immunol. Lett."},{"key":"57879_CR44","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/ibd.21175","volume":"16","author":"CJ Beltr\u00e1n","year":"2010","unstructured":"Beltr\u00e1n, C. J. et al. Characterization of the novel ST2\/IL-33 system in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 16, 1097\u20131107 (2010).","journal-title":"Inflamm. Bowel Dis."},{"key":"57879_CR45","doi-asserted-by":"publisher","first-page":"8017","DOI":"10.1073\/pnas.0912678107","volume":"107","author":"L Pastorelli","year":"2010","unstructured":"Pastorelli, L. et al. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1\/Th2 driven enteritis. Proc. Natl Acad. Sci. USA 107, 8017\u20138022 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"57879_CR46","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.2353\/ajpath.2010.100378","volume":"177","author":"J Sponheim","year":"2010","unstructured":"Sponheim, J. et al. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am. J. Pathol. 177, 2804\u20132815 (2010).","journal-title":"Am. J. Pathol."},{"key":"57879_CR47","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00535-010-0245-1","volume":"45","author":"A Kobori","year":"2010","unstructured":"Kobori, A. et al. Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J. Gastroenterol. 45, 999\u20131007 (2010).","journal-title":"J. Gastroenterol."},{"key":"57879_CR48","doi-asserted-by":"publisher","first-page":"e62144","DOI":"10.1371\/journal.pone.0062144","volume":"8","author":"A Latiano","year":"2013","unstructured":"Latiano, A. et al. Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease. PLoS One 8, e62144 (2013).","journal-title":"PLoS One"},{"key":"57879_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/cei.12285","volume":"177","author":"G Fonseca-Camarillo","year":"2014","unstructured":"Fonseca-Camarillo, G., Furuzawa-Carballeda, J., Granados, J. & Yamamoto-Furusho, J. K. Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study. Clin. Exp. Immunol. 177, 64\u201375 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"57879_CR50","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1136\/gutjnl-2017-315494","volume":"68","author":"R Gaujoux","year":"2019","unstructured":"Gaujoux, R. et al. Cell-centred meta-analysis reveals baseline predictors of anti-TNF\u03b1 non-response in biopsy and blood of patients with IBD. Gut 68, 604\u2013614 (2019).","journal-title":"Gut"},{"key":"57879_CR51","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3390\/ijms18081827","volume":"18","author":"S Zwicker","year":"2017","unstructured":"Zwicker, S., Lira-Junior, R., H\u00f6\u00f6g, C., Almer, S. & Bostr\u00f6m, E. A. Systemic Chemokine Levels with \u201cGut-Specific\u201d Vedolizumab in Patients with Inflammatory Bowel Disease-A Pilot Study. Int J. Mol. Sci. 18, 1827 (2017).","journal-title":"Int J. Mol. Sci."},{"key":"57879_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep31727","volume":"6","author":"Y Hathout","year":"2016","unstructured":"Hathout, Y. et al. Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children. Sci. Rep. 6, 31727 (2016).","journal-title":"Sci. Rep."},{"key":"57879_CR53","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1242\/jcs.030627","volume":"121","author":"D Pfaff","year":"2008","unstructured":"Pfaff, D. et al. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes. J. cell Sci. 121, 3842\u20133850 (2008).","journal-title":"J. cell Sci."},{"key":"57879_CR54","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3389\/fphar.2019.00691","volume":"10","author":"A Grandi","year":"2019","unstructured":"Grandi, A. et al. Targeting the Eph\/Ephrin System as Anti-Inflammatory Strategy in IBD. Front. Pharmacol. 10, 691 (2019).","journal-title":"Front. Pharmacol."},{"key":"57879_CR55","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1053\/j.gastro.2015.07.006","volume":"149","author":"JR Kelsen","year":"2015","unstructured":"Kelsen, J. R. et al. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease. Gastroenterology 149, 1415\u20131424 (2015).","journal-title":"Gastroenterology"},{"key":"57879_CR56","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.2174\/092986709788682155","volume":"16","author":"JR Kanwar","year":"2009","unstructured":"Kanwar, J. R., Kanwar, R. K., Burrow, H. & Baratchi, S. Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr. Medicinal Chem. 16, 2373\u20132394 (2009).","journal-title":"Curr. Medicinal Chem."},{"key":"57879_CR57","doi-asserted-by":"publisher","first-page":"1367120","DOI":"10.3389\/fimmu.2024.1367120","volume":"15","author":"N Eiza","year":"2024","unstructured":"Eiza, N., Sabag, A., Kessler, O., Toubi, E. & Vadasz, Z. Soluble CD72, is a T-cell activator probably via binding to CD6 in homeostasis and autoimmunity. Front Immunol. 15, 1367120 (2024).","journal-title":"Front Immunol."},{"key":"57879_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.253","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer. Clin. Transl. Med. 11, e253 (2021).","journal-title":"Clin. Transl. Med."},{"key":"57879_CR59","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/gene.2010.26","volume":"11","author":"C Ridruechai","year":"2010","unstructured":"Ridruechai, C. et al. Association analysis of susceptibility candidate region on chromosome 5q31 for tuberculosis. Genes Immun. 11, 416\u2013422 (2010).","journal-title":"Genes Immun."},{"key":"57879_CR60","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/cbr.2023.0022","volume":"38","author":"X Shen","year":"2023","unstructured":"Shen, X. et al. 4-1BB Targeting Immunotherapy: Mechanism, Antibodies, and Chimeric Antigen Receptor T. Cancer Biother. radiopharmaceuticals 38, 431\u2013444 (2023).","journal-title":"Cancer Biother. radiopharmaceuticals"},{"key":"57879_CR61","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3748\/wjg.v10.i5.620","volume":"10","author":"MC Li","year":"2004","unstructured":"Li, M. C. et al. IL-10 and its related cytokines for treatment of inflammatory bowel disease. World J. Gastroenterol. 10, 620\u2013625 (2004).","journal-title":"World J. Gastroenterol."},{"key":"57879_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1176639","volume":"14","author":"L Li","year":"2023","unstructured":"Li, L. et al. CCL13 and human diseases. Front Immunol. 14, 1176639 (2023).","journal-title":"Front Immunol."},{"key":"57879_CR63","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1111\/1751-7915.14059","volume":"15","author":"HG Wang","year":"2022","unstructured":"Wang, H. G. et al. Cepharanthine ameliorates dextran sulphate sodium-induced colitis through modulating gut microbiota. Microb. Biotechnol. 15, 2208\u20132222 (2022).","journal-title":"Microb. Biotechnol."},{"key":"57879_CR64","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.3324\/haematol.2021.280444","volume":"107","author":"B Rambaldi","year":"2022","unstructured":"Rambaldi, B. et al. Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation. Haematologica 107, 2617\u20132629 (2022).","journal-title":"Haematologica"},{"key":"57879_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112225","volume":"134","author":"LF Lincheta","year":"2024","unstructured":"Lincheta, L. F. et al. Long-term therapy with itolizumab is safe and effective for patients with moderate to severe psoriasis: Results from an expanded-access program. Int Immunopharmacol. 134, 112225 (2024).","journal-title":"Int Immunopharmacol."},{"key":"57879_CR66","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41591-022-01680-y","volume":"28","author":"M Uzzan","year":"2022","unstructured":"Uzzan, M. et al. Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity. Nat. Med 28, 766\u2013779 (2022).","journal-title":"Nat. Med"},{"key":"57879_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45616-1","volume":"15","author":"J Hao","year":"2024","unstructured":"Hao, J. et al. Dysregulation of Wnt\/\u03b2-catenin signaling contributes to intestinal inflammation through regulation of group 3 innate lymphoid cells. Nat. Commun. 15, 2820 (2024).","journal-title":"Nat. Commun."},{"key":"57879_CR68","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12, e1001779 (2015).","journal-title":"PLoS Med"},{"key":"57879_CR69","doi-asserted-by":"crossref","unstructured":"Chen, T. & Guestrin, C. XGBoost: A Scalable Tree Boosting System. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. San Francisco, California, USA: Association for Computing Machinery, 2016:785\u2013794.","DOI":"10.1145\/2939672.2939785"},{"key":"57879_CR70","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg, S. M. et al. From Local Explanations to Global Understanding with Explainable AI for Trees. Nat. Mach. Intell. 2, 56\u201367 (2020).","journal-title":"Nat. Mach. Intell."},{"key":"57879_CR71","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/bioinformatics\/btn209","volume":"24","author":"K Strimmer","year":"2008","unstructured":"Strimmer, K. fdrtool: a versatile R package for estimating local and tail area-based false discovery rates. Bioinformatics 24, 1461\u20131462 (2008).","journal-title":"Bioinformatics"},{"key":"57879_CR72","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","volume":"28","author":"S Burgess","year":"2017","unstructured":"Burgess, S., Bowden, J., Fall, T., Ingelsson, E. & Thompson, S. G. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants. Epidemiol. (Camb., Mass) 28, 30\u201342 (2017).","journal-title":"Epidemiol. (Camb., Mass)"},{"key":"57879_CR73","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess, S. & Thompson, S. G. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur. J. Epidemiol. 32, 377\u2013389 (2017).","journal-title":"Eur. J. Epidemiol."},{"key":"57879_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani, G., Tilling, K. & Davey Smith, G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet 13, e1007081 (2017).","journal-title":"PLoS Genet"},{"key":"57879_CR75","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 10, e1004383 (2014).","journal-title":"PLoS Genet"},{"key":"57879_CR76","unstructured":"The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580\u2013585 (2013)."},{"key":"57879_CR77","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"57879_CR78","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"57879_CR79","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T., & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"57879_CR80","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013d1082 (2018).","journal-title":"Nucleic Acids Res."},{"key":"57879_CR81","doi-asserted-by":"publisher","first-page":"D1302","DOI":"10.1093\/nar\/gkaa1027","volume":"49","author":"D Ochoa","year":"2021","unstructured":"Ochoa, D. et al. Open Targets Platform: supporting systematic drug-target identification and prioritisation. Nucleic Acids Res. 49, D1302\u2013d1310 (2021).","journal-title":"Nucleic Acids Res."},{"key":"57879_CR82","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 52, D1465\u2013d1477 (2024).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57879-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57879-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57879-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T22:59:29Z","timestamp":1742857169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57879-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57879"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57879-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"22 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2813"}}